OCX
Oncocyte Corporation
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
oncocyte is focused on the discovery, development, and commercialization of non-invasive, liquid biopsy diagnostics to facilitate clinical decision making in the early detection of cancer. the company's pipeline is focused on molecular tests for areas of high unmet need - lung, breast, and bladder cancers - where the current standard of diagnostic care is often ambiguous, costly, and involves invasive surgical procedures. oncocyte's diagnostics are developed based on a proprietary set of biomarkers that have been shown to differentiate benign from malignant nodules or masses. for more information, visit www.oncocyte.com.
Market Cap: 24.9 Million
Primary Exchange: NASDAQ
Website: http://www.oncocyte.com/
Shares Outstanding: 8.26 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.89636065300303
Sector: Manufacturing
Industry: In-Vitro Diagnostic Substance Manufacturing
Ethical Flags
Longest drawdown: 3349 trading days
From: 2016-01-05 To: 2024-03-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|